Antimicrobial resistant in Gram-negative bacilli: Enterobacteriaceae and non-fermenting bacilli isolated at Sominé DOLO Hospital of Mopti, Mali
DOI:
https://doi.org/10.30574/gscbps.2022.18.1.0021Keywords:
Gram-negative bacilli, Anti-microbial resistant, Rational use of antibioticsAbstract
Background: β-lactams and carbapenems. are the major antibiotics used to treat gram-negative bacteria and non-fermenting bacilli. However, the increasing production of β-lactamase and carbapenemase limits the therapeutic options. Our study aims to determine the resistant phenotypes of these bacteria while describing their epidemiological aspect.
Material and Methods: This was a cross-sectional study by consecutive enrollment from January 2018 to December 2019 at Sominé DOLO Hospital of Mopti, Mali. We performed manual method for bacteria culture, identification and antibiotics sensitivity testing. The antibiotics sensitivity testing was accessed by the diffusion method according to CA-SFM/EUCAST (“Comité de l’Antibiogramme de la Société Française de Microbiologie” / European Committee on Antimicrobial Susceptibility Testing) recommendations V1.0 february 2018 and V2.0 may 2019 2019 V.2.0. May recommendation released in 2019. Data were analyzed by software R 4.0.3 GUI 1.73 Catalina build (7892).
Results: At all 904 samples were included in this study. Out of the 904 cultures, 297 sample (32.85%) were positive. The rates of enzymes production were as follow: Extended-spectrum ß-lactamase (ESBL) 56.42% (101/179), cepholosporinase hyperproduction (HCASE) 15.64% (28/179), cephalosporinase production (CASE) 6.14% (11/179), penicillinase hyperproduction (HP) 5.58% (10/179), carbapenemase production (CP) 6.14% (11/179) and savage strains 10.05% (18/179).
Conclusion: Our data showed a high prevalence of resistance to β-lactamins ß-talactamins and carbapenemes in gram-negative bacteria and non-fermenting bacillus bacilli. The A high level of β-lactamase and carbapenemase production by gram negative bacillus were also reported by others authors calls for the rational use of antibiotic in hospital setting.
Metrics
References
Paterson DL. Resistance in gram-negative bacteria: Enterobacteriaceae. Am. J. Infect. Control. 2006; 34: S20–S28, S64–S73.
Pitout JD, Laupland KB. Extended-spectrum beta-lactamase-producing Enterobacteriaceae: an emerging public-health concern. Lancet Infect Dis. 2008; 8(3):159–66.
World Health Organization 2017: global priority list of antibiotic resistant – bacteria to guide research, discovery, and development of news antibiotics. Accessed June 2, 2021: https://www.who.int/medicines/publications/WHO-PPL-Short_Summary_25Feb-ET_NM_WHO.pdf.
Livermore DM, Woodford N. The beta-lactamase threat in Enterobacteriaceae, Pseudomonas and Acinetobacter. Trends Microbiol. 2006; 14: 413–420.
The World Bank Annual Report 2016. Accessed November 12, 2021: https://openknowledge.worldbank.org/handle/10986/24985.
Fissou Henry Yandai, Guelmbaye Ndoutamia, Bessimbaye Nadlaou and al. Prevalence and resistance profile of Escherichia coli and Klebsielle pneumoniae isolated from urinary tract infections in N’Djamena, Tchad. Int. J. Biol. Chem. Sci. 2019; 13(4): 2065-2073.
Ebongue CO, Tsiazok MD, Nda Mefo’o JP, Ngaba GP, Beyiha G, Adiogo D. Evolution de la resistance aux antibiotiques des Entérobactéries isolées à l’hopital Général de Douala de 2005 à 2012. Pan. Afr. Med. J. 2015; 20 : 227.
Sangare SA, Rondinaud E, Maataoui N, Maiga AI, Guindo I, Maiga A, et al. Very high prevalence of extended-spectrum beta-lactamase producing Enterobacteriaceae in bacteriemic patients hospitalized in teaching hospitals in Bamako,Mali. PLoS ONE . 2017; 12(2): e0172652.
Ouedraogo AS, Sanou M, Kissou A, Sanou S, Solare H, Kabore F, et al. High prevalence of extended spectrum β-lactamase producing Enterobacteriaceae among clinical isolates in Burkina-Faso. BMC Infect Dis. 2016; 16: 326.
Samba Adama Sanagre, Almoustapha Issiaka Maiga, Ibrehima Guindo and al. Prevalence of ESBL-producing Enterobactericeae isolated from blood cultures in Mali. J Infect Dev Ctries. 2016; 10(10): 1059-1064.
Obeng-Nkrumah N, Twum-Danso K, Krogfelt KA, Newman MJ. High levels of extended-spectrum beta-lactamases in a major teaching hospital in Ghana. The need to regular monitoring and evaluation of antibiotic resistance. AmJ Trop Med Hyg. 2013; 89(5): 960-4.
Ogbolu DO, Daini AO, Ogunledun A, et al. High levels of multidrug resistance in clinical isolates of gram-negative pathogens from Nigeria. Int J Antimicrob Agents. 2011; 37(1): 62-6.
Raymond B, Dahlia M, Alexandre M, et al. Increasing prevalence of antimicrobial resistance among Enterobacteriaceae uropathogens in Bangui. Central African Republic. J Infect Dev Ctries. 2009; 3(3): 187-90.
Oumar Ouchar Mahamat, Monon Lounnas, Mallorie Hide al. High prevalence and characterization of extended-spectrum β-lactamse production Enterobacteriaceae in Chadian hospitals. BMC Infections Diseases. 2019; 19(1): 205.
Downloads
Published
How to Cite
Issue
Section
License
This work is licensed under a Creative Commons Attribution-NonCommercial-ShareAlike 4.0 International License.